MedTrace Logo

The Effects of Aldara as an Adjunct to Laser Treatment

NCT00979550 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2018-03-22

Study results available
· View outcomes & findings →

Summary

The primary objective is to determine the effects of Aldara on the cosmetic outcome of laser treatment of vascular malformations.

Conditions

  • Port Wine Stains

Interventions

DRUG

Imiquimod

commercially available topical antiviral drug

DRUG

non-medicated petroleum cream

Over the counter topical cream used to aid the healing process in skin lesions

Sponsors & Collaborators

  • Graceway Pharmaceuticals, LLC

    collaborator INDUSTRY

  • Henry Vasconez

    lead OTHER

Principal Investigators

  • Henry C. Vasconez, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00979550 on ClinicalTrials.gov